Enzymatic characterization of TEM-63, a TEM-type extended spectrum β-lactamase expressed in three different genera of Enterobacteriaceae from South Africa
- 31 August 2001
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 40 (4) , 199-201
- https://doi.org/10.1016/s0732-8893(01)00266-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Complexity and Diversity of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Isolated in 1994 and 1996 at a Teaching Hospital in Durban, South AfricaAntimicrobial Agents and Chemotherapy, 2001
- Updated Sequence Information for TEM β-Lactamase GenesAntimicrobial Agents and Chemotherapy, 1999
- β-Lactamases Responsible for Resistance to Expanded-Spectrum Cephalosporins in Klebsiella pneumoniae , Escherichia coli , and Proteus mirabilis Isolates Recovered in South AfricaAntimicrobial Agents and Chemotherapy, 1998
- A natural polymorphism in β-lactamase is a global suppressorProceedings of the National Academy of Sciences, 1997
- SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patientsAntimicrobial Agents and Chemotherapy, 1995
- Sequences of MGH-1, YOU-1, and YOU-2 extended-spectrum beta-lactamase genesAntimicrobial Agents and Chemotherapy, 1993
- Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1989
- Extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1989
- Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1988
- Novel R-factor borne β-lactamase of Escherichia coli confering resistance to cephalosporinsInfection, 1987